Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cells

View/ Open
Author
Welch, Moira M.
Lopez, Jose M.
Joung, J. Keith
Published Version
https://doi.org/10.1038/nbt.3620Metadata
Show full item recordCitation
Kleinstiver, Benjamin P., Shengdar Q. Tsai, Michelle S. Prew, Nhu T. Nguyen, Moira M. Welch, Jose M. Lopez, Zachary R. McCaw, Martin J. Aryee, and J. Keith Joung. 2016. “Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cells.” Nature biotechnology 34 (8): 869-874. doi:10.1038/nbt.3620. http://dx.doi.org/10.1038/nbt.3620.Abstract
The activities and genome-wide specificities of CRISPR-Cas Cpf1 nucleases1 are not well defined. We show that two Cpf1 nucleases from Acidaminococcus sp. BV3L6 and Lachnospiraceae bacterium ND2006 (AsCpf1 and LbCpf1, respectively) have on-target efficiencies in human cells comparable with those of the widely used Streptococcus pyogenes Cas9 (SpCas9)2–5. We also report that four to six bases at the 3’ end of the short CRISPR RNA (crRNA) used to program Cpf1 nucleases are insensitive to single base mismatches, but that many of the other bases in this region of the crRNA are highly sensitive to single or double substitutions. Using GUIDE-seq and targeted deep sequencing analyses performed with both Cpf1 nucleases, we were unable to detect off-target cleavage for more than half of 20 different crRNAs. Our results suggest that AsCpf1 and LbCpf1 are highly specific in human cells.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980201/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:29739152
Collections
- FAS Scholarly Articles [17845]
- HMS Scholarly Articles [17714]
- SPH Scholarly Articles [6329]
Contact administrator regarding this item (to report mistakes or request changes)